Esomeprazole Magnesium Patent Expiration
Esomeprazole Magnesium was first introduced by Astrazeneca Pharmaceuticals Lp
Esomeprazole Magnesium Patents
Given below is the list of patents protecting Esomeprazole Magnesium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Esomeprazole Magnesium | US10076494 | Stable orally disintegrating pharmaceutical compositions | Dec 08, 2036 | Dexcel |
| Esomeprazole Magnesium | US10835488 | Stable orally disintegrating pharmaceutical compositions | Dec 08, 2036 | Dexcel |
| Nexium |
US6428810 (Pediatric) | Pharmaceutical formulation comprising omeprazole |
May 03, 2020
(Expired) | Astrazeneca |
| Nexium 24hr |
US6428810 (Pediatric) | Pharmaceutical formulation comprising omeprazole |
May 03, 2020
(Expired) | Astrazeneca Lp |
| Nexium | US6428810 | Pharmaceutical formulation comprising omeprazole |
Nov 03, 2019
(Expired) | Astrazeneca |
| Nexium 24hr | US6428810 | Pharmaceutical formulation comprising omeprazole |
Nov 03, 2019
(Expired) | Astrazeneca Lp |
| Nexium |
US6147103 (Pediatric) | Omeprazole process and compositions thereof |
Apr 09, 2019
(Expired) | Astrazeneca |
| Nexium |
US6166213 (Pediatric) | Omeprazole process and compositions thereof |
Apr 09, 2019
(Expired) | Astrazeneca |
| Nexium |
US6191148 (Pediatric) | Omerazole process and compositions thereof |
Apr 09, 2019
(Expired) | Astrazeneca |
| Nexium |
US6369085 (Pediatric) | Form of S-omeprazole |
Nov 25, 2018
(Expired) | Astrazeneca |
| Nexium |
US7411070 (Pediatric) | Form of S-omeprazole |
Nov 25, 2018
(Expired) | Astrazeneca |
| Nexium |
US8466175 (Pediatric) | Form of S-omeprazole |
Nov 25, 2018
(Expired) | Astrazeneca |
| Nexium 24hr |
US6369085 (Pediatric) | Form of S-omeprazole |
Nov 25, 2018
(Expired) | Astrazeneca Lp |
| Nexium 24hr |
US7411070 (Pediatric) | Form of S-omeprazole |
Nov 25, 2018
(Expired) | Astrazeneca Lp |
| Nexium 24hr |
US7411070 (Pediatric) | Form of S-omeprazole |
Nov 18, 2018
(Expired) | Astrazeneca Lp |
| Nexium | US6147103 | Omeprazole process and compositions thereof |
Oct 09, 2018
(Expired) | Astrazeneca |
| Nexium | US6166213 | Omeprazole process and compositions thereof |
Oct 09, 2018
(Expired) | Astrazeneca |
| Nexium | US6191148 | Omerazole process and compositions thereof |
Oct 09, 2018
(Expired) | Astrazeneca |
| Nexium | US6369085 | Form of S-omeprazole |
May 25, 2018
(Expired) | Astrazeneca |
| Nexium | US7411070 | Form of S-omeprazole |
May 25, 2018
(Expired) | Astrazeneca |
| Nexium | US8466175 | Form of S-omeprazole |
May 25, 2018
(Expired) | Astrazeneca |
| Nexium 24hr | US6369085 | Form of S-omeprazole |
May 25, 2018
(Expired) | Astrazeneca Lp |
| Nexium 24hr | US7411070 | Form of S-omeprazole |
May 25, 2018
(Expired) | Astrazeneca Lp |
| Nexium 24hr | US7411070 | Form of S-omeprazole |
May 18, 2018
(Expired) | Astrazeneca Lp |
| Nexium |
US5900424 (Pediatric) | Omeprazole magnesium salt form |
Nov 04, 2016
(Expired) | Astrazeneca |
| Nexium 24hr |
US5900424 (Pediatric) | Omeprazole magnesium salt form |
Nov 04, 2016
(Expired) | Astrazeneca Lp |
| Nexium | US5900424 | Omeprazole magnesium salt form |
May 04, 2016
(Expired) | Astrazeneca |
| Nexium 24hr | US5900424 | Omeprazole magnesium salt form |
May 04, 2016
(Expired) | Astrazeneca Lp |
| Nexium |
US5714504 (Pediatric) | Compositions |
Aug 03, 2015
(Expired) | Astrazeneca |
| Nexium 24hr |
US5714504 (Pediatric) | Compositions |
Aug 03, 2015
(Expired) | Astrazeneca Lp |
| Nexium |
US5690960 (Pediatric) | Pharmaceutical formulation of omeprazole |
May 25, 2015
(Expired) | Astrazeneca |
| Nexium 24hr |
US5690960 (Pediatric) | Pharmaceutical formulation of omeprazole |
May 25, 2015
(Expired) | Astrazeneca Lp |
| Nexium | US5714504 | Compositions |
Feb 03, 2015
(Expired) | Astrazeneca |
| Nexium 24hr | US5714504 | Compositions |
Feb 03, 2015
(Expired) | Astrazeneca Lp |
| Nexium |
US5877192 (Pediatric) | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
Nov 27, 2014
(Expired) | Astrazeneca |
| Nexium |
US6875872 (Pediatric) | Compounds |
Nov 27, 2014
(Expired) | Astrazeneca |
| Nexium 24hr |
US5877192 (Pediatric) | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
Nov 27, 2014
(Expired) | Astrazeneca Lp |
| Nexium 24hr |
US6875872 (Pediatric) | Compounds |
Nov 27, 2014
(Expired) | Astrazeneca Lp |
| Nexium | US5690960 | Pharmaceutical formulation of omeprazole |
Nov 25, 2014
(Expired) | Astrazeneca |
| Nexium 24hr | US5690960 | Pharmaceutical formulation of omeprazole |
Nov 25, 2014
(Expired) | Astrazeneca Lp |
| Nexium | US5877192 | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
May 27, 2014
(Expired) | Astrazeneca |
| Nexium | US6875872 | Compounds |
May 27, 2014
(Expired) | Astrazeneca |
| Nexium 24hr | US5877192 | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
May 27, 2014
(Expired) | Astrazeneca Lp |
| Nexium 24hr | US6875872 | Compounds |
May 27, 2014
(Expired) | Astrazeneca Lp |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Esomeprazole Magnesium's patents.
Latest Legal Activities on Esomeprazole Magnesium's Patents
Given below is the list recent legal activities going on the following patents of Esomeprazole Magnesium.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 09 May, 2024 | US10835488 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 14 Feb, 2022 | US10076494 |
| Recordation of Patent Grant Mailed Critical | 17 Nov, 2020 | US10835488 |
| Patent Issue Date Used in PTA Calculation Critical | 17 Nov, 2020 | US10835488 |
| Email Notification Critical | 29 Oct, 2020 | US10835488 |
| Issue Notification Mailed Critical | 28 Oct, 2020 | US10835488 |
| Email Notification Critical | 13 Oct, 2020 | US10835488 |
| Mailing Corrected Notice of Allowability | 13 Oct, 2020 | US10835488 |
| Dispatch to FDC | 10 Oct, 2020 | US10835488 |
| Corrected Notice of Allowability | 07 Oct, 2020 | US10835488 |
Esomeprazole Magnesium's Family Patents
Explore Our Curated Drug Screens
Esomeprazole Magnesium Generic API Manufacturers
Several generic applications have been filed for Esomeprazole Magnesium. The first generic version for Esomeprazole Magnesium was by Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa and was approved on Jan 26, 2015. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Oct 23, 2024.
Given below is the list of companies who have filed for Esomeprazole Magnesium generic, along with the locations of their manufacturing plants worldwide.
1. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 20, 2017 |
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 20, 2017 |
2. AMNEAL PHARMS NY
Amneal Pharmaceuticals Of Ny Llc has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Amneal Pharms Ny.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Apr 10, 2019 |
| EQ 20MG BASE | capsule, delayed release | Over the counter | ORAL | N/A | Jun 5, 2019 |
3. ANDA REPOSITORY
Anda Repository Llc has filed for 1 generic for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Anda Repository.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed release | Over the counter | ORAL | N/A | Mar 15, 2023 |
4. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 1 generic for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed release | Over the counter | ORAL | N/A | Oct 16, 2017 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
| United States |
| |||||||||
5. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet, delayed release | Over the counter | ORAL | N/A | Jul 12, 2023 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Apr 21, 2016 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
6. CIPLA
Cipla Ltd has filed for 3 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE/PACKET | for suspension, delayed release | Prescription | ORAL | AB | Mar 23, 2020 |
| EQ 10MG BASE/PACKET | for suspension, delayed release | Prescription | ORAL | AB | Mar 23, 2020 |
| EQ 40MG BASE/PACKET | for suspension, delayed release | Prescription | ORAL | AB | Mar 23, 2020 |
Manufacturing Plant Locations New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
7. CISEN
Cisen Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Cisen.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Sep 22, 2020 |
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Sep 22, 2020 |
8. CSPC OUYI
Cspc Ouyi Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Cspc Ouyi.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 2, 2020 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 2, 2020 |
Manufacturing Plant Locations New
Cspc Ouyi's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Cspc Ouyi as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| China |
| |||
9. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed release | Over the counter | ORAL | N/A | Apr 30, 2024 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Sep 25, 2015 |
10. ETHYPHARM
Ethypharm Sa has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Ethypharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Mar 31, 2021 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Mar 31, 2021 |
Manufacturing Plant Locations New
Ethypharm's manufacturing plants are situated in 2 countries - France, United States. Given below are the details of these plant locations as well as the firm names of Ethypharm as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| France |
| |||||
| United States |
| |||||
11. GLENMARK SPECLT
Glenmark Specialty Sa has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Glenmark Speclt.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | May 10, 2019 |
| EQ 20MG BASE | capsule, delayed release | Over the counter | ORAL | N/A | Jun 11, 2024 |
12. GRANULES
Granules India Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Granules.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 18, 2023 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 18, 2023 |
Manufacturing Plant Locations New
Granules's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Granules as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||
| India |
| |||||||||||
13. GRAVITI PHARMS
Graviti Pharmaceuticals Private Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Graviti Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Mar 19, 2021 |
| EQ 20MG BASE | capsule, delayed release | Over the counter | ORAL | N/A | Jun 24, 2022 |
14. GUANGZHOU NOVAKEN
Guangzhou Novaken Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Guangzhou Novaken.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Nov 18, 2020 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Nov 18, 2020 |
15. HEC PHARM
Hec Pharm Usa Inc has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Hec Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | May 18, 2018 |
| EQ 20MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | May 18, 2018 |
Manufacturing Plant Locations New
Hec Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Hec Pharm as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| China |
| |||
16. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jun 2, 2020 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jun 2, 2020 |
17. INDCHEMIE HEALTH
Indchemie Health Specialties Pvt Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Indchemie Health.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Feb 26, 2021 |
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Feb 26, 2021 |
18. IVAX SUB TEVA PHARMS
Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Ivax Sub Teva Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jan 26, 2015 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jan 26, 2015 |
19. LANNETT CO INC
Lannett Co Inc has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Sep 1, 2017 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Sep 1, 2017 |
20. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 23, 2024 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 23, 2024 |
21. MARKSANS PHARMA
Marksans Pharma Ltd has filed for 1 generic for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Marksans Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed release | Over the counter | ORAL | N/A | Sep 29, 2023 |
Manufacturing Plant Locations New
Marksans Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Marksans Pharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
| India |
| |||
22. MYLAN
Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet, delayed release | Over the counter | ORAL | N/A | Jun 25, 2020 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Aug 3, 2015 |
Manufacturing Plant Locations New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
| Canada |
| |||||||||||||||||
| Ireland |
| |||||||||||||||||
23. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 1 generic for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed release | Discontinued | ORAL | N/A | Oct 16, 2019 |
24. P AND L
P And L Development Llc has filed for 1 generic for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by P And L.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet, delayed release | Discontinued | ORAL | N/A | Mar 5, 2019 |
25. PERRIGO R AND D
Perrigo R And D Co has filed for 1 generic for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Perrigo R And D.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed release | Over the counter | ORAL | N/A | Aug 18, 2017 |
26. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Prinston Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Mar 28, 2023 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Mar 28, 2023 |
27. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Apr 30, 2018 |
| EQ 20MG BASE | capsule, delayed release | Over the counter | ORAL | N/A | May 4, 2020 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||
28. TORRENT
Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Oct 19, 2015 |
| EQ 40MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Oct 19, 2015 |
Manufacturing Plant Locations New
Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||
| United States |
| |||||||||||
29. ZHEJIANG YONGTAI
Zhejiang Yongtai Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Zhejiang Yongtai.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 27, 2023 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 27, 2023 |
Manufacturing Plant Locations New
Zhejiang Yongtai's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Zhejiang Yongtai as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| China |
| |||
30. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | May 22, 2019 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | May 22, 2019 |
| EQ 20MG BASE/PACKET | for suspension, delayed release | Prescription | ORAL | AB | Jun 7, 2023 |
| EQ 40MG BASE/PACKET | for suspension, delayed release | Prescription | ORAL | AB | Jun 7, 2023 |